Linscott Walt Addison 4
4 · Intec Pharma Ltd. · Filed Feb 19, 2020
Insider Transaction Report
Form 4
Linscott Walt Addison
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-17+90,000→ 90,000 totalExercise: $0.43Exp: 2027-02-17→ Ordinary Shares (90,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on February 17, 2021 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through February 17, 2023.